Abstract
Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors (gliptins) are approved drugs for the treatment of hyperglycemia in patients with type 2 diabete......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
